Tech Company M&A Transactions
Integrated Diagnostics Acquisition
On 7/10/2018, Integrated Diagnostics was acquired by Biodesix. The companies did not announce specifics regarding acquisition price or deal terms.
Transaction Overview
Company Name
Acquired By
Announced On
7/10/2018
Transaction Type
M&A
Amount
Unknown
M&A Terms
The agreement includes the XL2 test, Indi's lead oncology product, which offers a noninvasive means of ruling out cancer for patients with suspicious lung nodules. Financial terms of the deal were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
219 Terry Ave. North 100
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Overview
Indi is creating powerful new tools to help physicians diagnose complex diseases with a non-invasive blood test. By measuring multiple biomarkers that serve as sentinels of disease we are creating tests that help physicians diagnose disease states with greater accuracy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Albert Luderer
Chief Scientific Officer
Paul Kearney
Co-Founder
David Galas
Co-Founder
James Heath
Co-Founder
Lee Hood
VP - Bus. Development
Doug Fisher
Browse more venture capital transactions:
Prev: 7/10/2018: EBTH venture capital transaction
Next: 7/10/2018: Topbox venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs